Bisphosphonates for Osteoporosis.
N Engl J Med. 2010 Nov 18;363(21):2027-2035
Authors: Favus MJ
A 67-year-old woman is referred by her primary care physician for treatment of osteoporosis and progressive bone loss. Oral bisphosphonate therapy is recommended. Bisphosphonates suppress bone resorption by interfering with osteoclast activity. Several of these agents have been shown to prevent fractures and increase bone mineral density in patients with osteoporosis. Long-term bisphosphonate therapy has been associated with osteonecrosis of the jaw and atypical femur fractures.
PMID: 21083387 [PubMed - as supplied by publisher]